Effect of Month of Birth on the Risk of Developing Psoriasis
Abstract
Introduction: Psoriasis is an immunemediated dermatosis characterized by chronic inflammation, abnormal proliferation and aberrant differentiation of keratinocytes, hyperplastic blood vessels and infiltration of inflammatory cells. Psoriasis is a multifactorial disease and is influenced by genetics and epigenetic modifications that can be triggered by environmental factors. Climate and sun exposure may affect psoriasis prevalence and the ultraviolet radiation is a useful treatment. Our objective was to evaluate the relationship between the month of birth and the risk of developing psoriasis.
Methods: The monthly distribution of births of patients with psoriasis (n = 755) was compared to that of a control population, comprised by Portuguese individual born during the same period and from the same region (n = 6 560 032).
Results: Birth rate of psoriasis patients decreased in October (OR 0.74; 95% CI 0.55 – 0.99; p 0.041). After Bonferroni correction and after grouping the months by trimesters, no statistical significant differences were found.
Conclusion: Our results may be related to the particular meteorological characteristics of Portugal that may lead to stabilization of the vitamin D synthesis during the whole year. The perception of the environmental influence on the development of a specific pathology is very important because it allows the establishment of preventive measures that will reduce disease incidence.
Downloads
References
Deng Y, Chang C, Lu Q. The inflammatory response in psoriasis: a comprehensive. Clin Rev Allergy Immunol. 2016: 50:377-89.
Boehncke WH, Schön MP. Psoriasis. Lancet.2015;386: 983-94.
Torres T, Sales R, Vasconcelos C, Selores M. Psoriasis and cardiovascular disease. Acta Med Port.; 26:601-7.
Ritchlin CT, Kavanaugh A, Gladman DD, Mease PJ, Helliwell P, Boehncke WH, et al. Treatment recommendations for psoriatic arthritis. Ann Rheum Dis. 2009; 68:1387-94.
Balato N, Di Costanzo L, Patruno C, Patrì A, Ayala F. Effect of weather and environmental factors on the clinical course of psoriasis. Occup Environ Med. 2013; 70:600.
Juzeniene A, Grigalavicius M, Juraleviciute M, Grant WB. Phototherapy and vitamin D. Clin Dermatol. 2016;
:548-55.
Mattozzi C, Paolino G, Richetta AG, Calvieri S. Psoriasis, vitamin D and the importance of the cutaneous barrier’s integrity: An update. J Dermatol.2016; 43:507-14.
Disanto G, Chaplin G, Morahan JM, Giovannoni G, Hyppönen E, Ebers GC, et al. Month of birth, vitamin
D and risk of immune-mediated disease: a case control study. BMC Med.2012; 10:69.
Orgaz-Molina J, Buendía-Eisman A, Arrabal-Polo MA, Ruiz JC, Arias-Santiago S. Deficiency of serum concentration of 25-hydroxyvitamin D in psoriatic patients: a case-control study. J Am Acad Dermatol. 2012:
:931-8.
Ricceri F, Pescitelli L, Tripo L, Prignano F. Deficiency of serum concentration of 25- hydroxyvitamin D correlates with severity of disease in chronic plaque psoriasis. J Am Acad Dermatol.2013; 68:511-2.
Khoo AL, Chai LY, Koenen HJ, Sweep FC, Joosten I, Netea MG, et al. Regulation of cytokine responses by
seasonality of vitamin D status in healthy individuals. Clin Exp Immunol.2011; 164:72-9.
Gorman S, Judge MA, Burchell JT, Turner DJ, Hart PH. 1,25-dihydroxyvitamin D3 enhances the ability of
transferred CD4+ CD25+ cells to modulate T helper type 2-driven asthmatic responses. Immunology.2010;
:181-92.
Wang TT, Nestel FP, Bourdeau V, Nagai Y, Wang Q, Liao J, et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol. 2004; 173:2909-12.
Søyland E, Heier I, Rodríguez-Gallego C, Mollnes TE, Johansen FE, Holven KB, et al. Sun exposure induces rapid immunological changes in skin and peripheral blood in patients with psoriasis. Br J Dermatol. 2011; 164:344-55.
Grytten N, Torkildsen Ø, Aarseth JH, Benjaminsen E, Celius EG, Dahl OP, et al. Month of birth as a latitude-dependent risk factor for multiple sclerosis in Norway. Mult Scler J.2013; 19:1028-34.
Torkildsen O, Aarseth J, Benjaminsen E, Celius E, Holmøy T, Kampman MT, et al. "onth of birth and risk of
multiple sclerosis: confounding and adjustments. Ann Clin Transl Neurol. 2014;1:141-4.
Menni C, Lowell WE, Bentzen J, Bergamaschi R, Martinelli Boneschi F, et al. Short and long term variation in ultraviolet radiation and multiple sclerosis. Int J Environ Res Public Health.2012; 9:685-97.
Bayes HK, Weir CJ, O’Leary C. Timing of birth and risk of multiple sclerosis in the Scottish population. Eur Neurol. 2010; 63:36-40.
Villar-Quiles RN, Matías-Guiu JA, Ortega G, González-Suárez I, Oreja-Guevara C, Matías-Guiu J. Analysis
of the relationship between the month of birth and risk of multiple sclerosis in a Spanish population. Eur Neurol. 2016; 76:202-9.
Barros P, de Sá JM, Sá MJ. Month of birth and risk of multiple sclerosis in a Portuguese population. Clin Neurol Neurosurg.2013; 115:1762-5.
Al-Garawi A, Carey VJ, Chhabra D, Mirzakhani H, Morrow J, Lasky-Su J, et al. The role of vitamin D in the transcriptional program of human pregnancy. PLoS One. 2016; 11:e0163832.
Munger KL, Åivo J, Hongell K, Soilu-Hänninen M, Surcel HM, Ascherio A. Vitamin D status during pregnancy and risk of multiple sclerosis in offspring of women in the Finnish maternity cohort. JAMA Neurol. 2016; 73:515-9.
Sharief S, Jariwala S, Kumar J, Muntner P, Melamed ML. Vitamin D levels and food and environmental allergies in the United States: Results from the National Health and Nutrition Examination Survey. J Allergy Clin Immunol. 2011; 127:1195-1202.
Chiu CY, Huang SY, Peng YC, Tsai MH, Hua MC, Yao TC, et al. Maternal vitamin D levels are inversely related to allergic sensitization and atopic diseases in early childhood. Pediatr Allergy Immunol. 2015; 25:337-43.
Bunyavanich S, Rifas-Shiman SL, Platts-Mills TA, Workman L, Sordillo JE, Camargo CA Jr, et al. Prenatal, perinatal, and childhood vitamin D exposure and their association with childhood allergic rhinitis and allergic
sensitization. J Allergy Clin Immunol. 2016; 137:1063-70.
Erkkola M, Kaila M, Nwaru BI, Kronberg-Kippilä C, Ahonen S, Nevalainen J, et al. Maternal vitamin D intake during pregnancy is inversely associated with asthma and allergic rhinitis in 5-year-old children. Clin Exp Allergy. 2009; 39:875-82.
Kun Z, Andrew JO, Prue H, Merci K, Jenny M, Stephen L, et al. Maternal vitamin D status during pregnancy and bone mass in offspring at 20 years of age: a prospective cohort study. J Bone Miner Res. 2014; 29:1088-95.
Javaid MK, Crozier SR, Harvey NC, Gale CR, Dennison EM, Boucher BJ, et al. Maternal vitamin D status during pregnancy and childhood bone mass at age 9 years: a longitudinal study. Lancet. 2006; 367: 36-43.
Takiishi T, Gysemans C, Bouillon R, Mathieu C. Vitamin D and diabetes. Endocrinol Metab Clin North Am.
; 39:419-46.
Brekke HK, Ludvigsson J. Vitamin D supplementation and diabetes-related autoimmunity. Pediatr Diabetes. 2007; 8:11-4.
Zipitis CS, Akobeng AK. Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis. Arch Dis Child. 2008; 93:512-7.
Magnus MC, Stene LC, Håberg SE, Nafstad P, Stigum H, London SJ, et al. Prospective study of maternal mid-pregnancy 25-hydroxyvitamin D level and early childhood respiratory disorders. Paediatr Perinat Epidemiol. 2013; 27:532-41.
Dirnagl U, Lauritzen M. Fighting publication bias: introducing the negative results section. J Cereb Blood Flow Metab, 2010; 30: 1263-4.
Dawodu A, Wagner CL. Mother-child vitamin d deficiency: an international perspective. Arch Dis Child. 2007; 92:737-40.
O’Riordan MN, Kiely M, Higgins JR, Cashman KD. Prevalence of suboptimal vitamin d status during pregnancy. Ir Med J. 2008; 101:240-3.
Holick M. Vitamin D deficiency. N Engl J Med. 2007; 357:266-81.
All articles in this journal are Open Access under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0).
